SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-013017
Filing Date
2020-05-13
Accepted
2020-05-13 18:07:47
Documents
1
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 27860
  Complete submission text file 0000899243-20-013017.txt   29197
Mailing Address 176 WEST BLITHEDALE AVE MILL VALLEY CA 94941
Business Address
PERRY MARK L (Reporting) CIK: 0001190270 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 20874660

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations